<DOC>
	<DOCNO>NCT01920698</DOCNO>
	<brief_summary>The objective trial compare safety , efficacy cost-effectiveness 2 therapeutic strategy ( optimal standard care therapy alone versus percutaneous MitraClip procedure optimal standard care therapy ) patient severe secondary mitral regurgitation . This trial French , multicenter randomize trial . Patients enrol clinically follow 2 year ( phone call 1 month , clinical visit 6 month , 12 month 24 month ) .</brief_summary>
	<brief_title>Multicentre Study Percutaneous Mitral Valve Repair MitraClip Device Patients With Severe Secondary Mitral Regurgitation</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Age &gt; 18 year old Severe secondary mitral regurgitation confirm Echocardiography Core Laboratory Characterized regurgitation volume &gt; 30 mL/beat regurgitant orifice area &gt; 20 mm2 New York heart Association Classâ‰¥ II . Left ventricular ejection fraction 15 % 40 % Minimum 1 hospitalization heart failure within 12 month precede randomization Assessed investigator optimal standard care therapy heart failure Assessed heart team eligible mitral surgery intervention Primary mitral regurgitation Myocardial infarction coronary bypass grafting surgery within 3 month prior randomization Cardiac resynchronization therapy within 3 month prior randomization Cardioversion within 3 month prior randomization Need cardiovascular surgery ( include registration cardiac transplant list ) Coronary angioplasty within 1 month prior randomization History mitral valve repair Active infection require current antibiotic therapy Terminal renal insufficiency ( renal replacement therapy ) Severe hepatic insufficiency Evidence stroke within 3 month prior randomization Concurrent medical condition life expectancy le 12 month Uncontrolled hypertension Known hypersensitivity nitinol Currently participate another trial Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Heart Valve Diseases</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Heart disease</keyword>
	<keyword>Mitral valve insufficiency</keyword>
</DOC>